Case report: Compound heterozygous NUP85 variants cause autosomal recessive primary microcephaly

Ethiraj Ravindran, Gaetan Lesca, Louis Januel, Linus Goldgruber, Achim Dickmanns, Henri Margot, Angela M Kaindl, Ethiraj Ravindran, Gaetan Lesca, Louis Januel, Linus Goldgruber, Achim Dickmanns, Henri Margot, Angela M Kaindl

Abstract

Nucleoporin (NUP) 85 is a member of the Y-complex of nuclear pore complex (NPC) that is key for nucleocytoplasmic transport function, regulation of mitosis, transcription, and chromatin organization. Mutations in various nucleoporin genes have been linked to several human diseases. Among them, NUP85 was linked to childhood-onset steroid-resistant nephrotic syndrome (SRNS) in four affected individuals with intellectual disability but no microcephaly. Recently, we broaden the phenotype spectrum of NUP85-associated disease by reporting NUP85 variants in two unrelated individuals with primary autosomal recessive microcephaly (MCPH) and Seckel syndrome (SCKS) spectrum disorders (MCPH-SCKS) without SRNS. In this study, we report compound heterozygous NUP85 variants in an index patient with only MCPH phenotype, but neither Seckel syndrome nor SRNS was reported. We showed that the identified missense variants cause reduced cell viability of patient-derived fibroblasts. Structural simulation analysis of double variants is predicted to alter the structure of NUP85 and its interactions with neighboring NUPs. Our study thereby further expands the phenotypic spectrum of NUP85-associated human disorder and emphasizes the crucial role of NUP85 in the brain development and function.

Keywords: MCPH-SCKS; NUP85; brain development; microcephaly; speech disorder.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2023 Ravindran, Lesca, Januel, Goldgruber, Dickmanns, Margot and Kaindl.

Figures

Figure 1
Figure 1
Phenotype of index patient with compound heterozygous NUP85 mutation. (A) Pedigree. (B) Pictures of affected individual (II.2). (C) MRI images of the head (sagittal) T2 images of II.2 shows reduced brain volume. (D) Representation of identified compound heterozygous variants by whole genome sequencing in the NUP85 cDNA c.454C > A in exon 6 (maternally inherited) and c.487C > A in exon 7 (paternally inherited) and NUP85 wild-type protein (p.L152I, p.L163I). (E) Mutations lie in the highly conserved region of the NUP85 protein across species. (F) Unchanged levels of total NUP85 protein in II.2-derived fibroblasts compared to controls [NUP85 (75kDa), actin (43kDa) (loading control)] (n = 3, one-way ANOVA, Tukey's multiple comparison test, p = 0.2973). (H) Cell viability in II.2-patient derived fibroblasts is significantly reduced compared to controls (n=8, one-way ANOVA, Tukey's multiple comparison test, ****p < 0.0001). (I) Structural overlay of human NUP85 based on PDBid 7R5K (purple) and the L152I/L163I double mutant (wheat). Top panel: Overlay of the overall structures; bottom panel: magnification of the hinge region (indicated by red line), the structures have been overlaid using the central region of the molecules. The mutations are located in this hinge region and are indicated in ball and stick mode. (J) Significant change of the interaction pattern due to mutations. Magnification of the interaction patterns as evaluated using the program Arpeggio under standard settings. Top panel wild-type, bottom panel-double mutant. The mutated residues are indicted in the colors as in (I).

References

    1. Beck M, Hurt E. The nuclear pore complex: understanding its function through structural insight. Nat Rev Mol Cell Biol. (2017) 18:73–89. 10.1038/nrm.2016.147
    1. Raices M, D'Angelo MA. Nuclear pore complexes and regulation of gene expression. Curr Opin Cell Biol. (2017) 46:26–32. 10.1016/j.ceb.2016.12.006
    1. Isabelle Loiodice AA, Gwenael R, van Overbeek M, Ellenberg J, Sibarita J-B, Doye V. The entire Nup107-160 complex, including three new members, is targeted as one entity to kinetochores in mitosis. Mol Biol Cell. (2004) 15:3333–44. 10.1091/mbc.e03-12-0878
    1. Braun DA, Lovric S, Schapiro D, Schneider R, Marquez J, Asif M, et al. . Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome. J Clin Invest. (2018) 128:4313–28. 10.1172/JCI98688
    1. Zuccolo M, Alves A, Galy V, Bolhy S, Formstecher E, Racine V, et al. . The human Nup107-160 nuclear pore subcomplex contributes to proper kinetochore functions. EMBO J. (2007) 26:1853–64. 10.1038/sj.emboj.7601642
    1. Lupu F, Alves A, Anderson K, Doye V, Lacy E. Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. Dev Cell. (2008) 14:831–42. 10.1016/j.devcel.2008.03.011
    1. Nofrini V, Di Giacomo D, Mecucci C. Nucleoporin genes in human diseases. Eur J Hum Genet. (2016) 24:1388–95. 10.1038/ejhg.2016.25
    1. Ravindran E, Juhlen R, Vieira-Vieira CH, Ha T, Salzberg Y, Fichtman B, et al. . Expanding the phenotype of NUP85 mutations beyond nephrotic syndrome to primary autosomal recessive microcephaly and Seckel syndrome spectrum disorders. Hum Mol Genet. (2021) 30:2068–81. 10.1055/s-0041-1739664
    1. von Bernuth H, Ravindran E, Du H, Frohler S, Strehl K, Kramer N, et al. . Combined immunodeficiency develops with age in immunodeficiency-centromeric instability-facial anomalies syndrome 2 (ICF2). Orphanet J Rare Dis. (2014) 9:116. 10.1186/s13023-014-0116-6
    1. Song Y, DiMaio F, Wang RY, Kim D, Miles C, Brunette T, et al. . High-resolution comparative modeling with RosettaCM. Structure. (2013) 21:1735–42. 10.1016/j.str.2013.08.005
    1. Jubb HC, Higueruelo AP, Ochoa-Montano B, Pitt WR, Ascher DB, Blundell TL. Arpeggio: a web server for calculating and visualising interatomic interactions in protein structures. J Mol Biol. (2017) 429:365–71. 10.1016/j.jmb.2016.12.004
    1. Mosalaganti S, Obarska-Kosinska A, Siggel M, Taniguchi R, Turonova B, Zimmerli CE, et al. . AI-based structure prediction empowers integrative structural analysis of human nuclear pores. Science. (2022) 376:eabm9506. 10.1126/science.abm9506
    1. Schuller AP, Wojtynek M, Mankus D, Tatli M, Kronenberg-Tenga R, Regmi SG, et al. . The cellular environment shapes the nuclear pore complex architecture. Nature. (2021) 598:667–71. 10.1038/s41586-021-03985-3
    1. Bley CJ, Nie S, Mobbs GW, Petrovic S, Gres AT, Liu X, et al. . Architecture of the cytoplasmic face of the nuclear pore. Science. (2022) 376:eabm9129. 10.1126/science.abm9129
    1. von Appen A, Kosinski J, Sparks L, Ori A, DiGuilio AL, Vollmer B, et al. . In situ structural analysis of the human nuclear pore complex. Nature. (2015) 526:140–3. 10.1038/nature15381
    1. Khan AU, Qu R, Ouyang J, Dai J. Role of nucleoporins and transport receptors in cell differentiation. Front Physiol. (2020) 11:239. 10.3389/fphys.2020.00239
    1. Zaqout S, Kaindl AM. Autosomal recessive primary microcephaly: not just a small brain. Front Cell Dev Biol. (2021) 9:784700. 10.3389/fcell.2021.784700
    1. Reza N, Khokha MK, Del Viso F. Nucleoporin gene expression in Xenopus tropicalis embryonic development. Int J Dev Biol. (2016) 60:181–8. 10.1387/ijdb.150317nr
    1. Colussi C, Grassi C. Epigenetic regulation of neural stem cells: the emerging role of nucleoporins. Stem Cells. (2021) 39:1601–14. 10.1002/stem.3444
    1. D'Angelo MA, Gomez-Cavazos JS, Mei A, Lackner DH, Hetzer MW, A. change in nuclear pore complex composition regulates cell differentiation. Dev Cell. (2012) 22:446–58. 10.1016/j.devcel.2011.11.021
    1. Smitherman M, Lee K, Swanger J, Kapur R, Clurman BE. Characterization and targeted disruption of murine Nup50, a p27(Kip1)-interacting component of the nuclear pore complex. Mol Cell Biol. (2000) 20:5631–42. 10.1128/MCB.20.15.5631-5642.2000
    1. Jacinto FV, Benner C, Hetzer MW. The nucleoporin Nup153 regulates embryonic stem cell pluripotency through gene silencing. Genes Dev. (2015) 29:1224–38. 10.1101/gad.260919.115
    1. Raices M, D'Angelo MA. Nuclear pore complexes are key regulators of oligodendrocyte differentiation and function. Neuron. (2019) 102:509–11. 10.1016/j.neuron.2019.04.025

Source: PubMed

3
Abonnere